Description and Brand Names
Drug information provided by: Merative, Micromedex®
US Brand Name
Bosutinib is used to treat chronic myeloid leukemia (CML) that is Philadelphia chromosome-positive (Ph+) in patients who are newly-diagnosed or who have used other treatments that did not work well. Leukemia is a type of cancer where the body makes abnormal white blood cells.
Bosutinib is an antineoplastic (cancer) medicine. It interferes with the growth of cancer cells, which are eventually destroyed by the body. Since the growth of normal cells may also be affected by bosutinib, other side effects can occur. Before you begin treatment, talk to your doctor about the benefits of this medicine as well as the possible risks of using it.
This medicine is available only with your doctor's prescription.
This product is available in the following dosage forms:
Portions of this document last updated: May 01, 2023
Copyright: © Merative US L.P. 1973, 2023. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.